-
CNS prophylaxis in diffuse large B-cell lymphoma: If, when, how and for whom?
16 January 2012
Tali Siegal, Neta Goldschmidt
Abstract: Central nervous system (CNS) relapse is an uncommon devastating complication of diffuse large B-cell lymphoma (DLBCL) that usually occurs within 2years from initial diagnosis. Its pathophysi...
-
Ex-vivo expansion of red blood cells: How real for transfusion in humans?
19 December 2011
Anna Rita Migliaccio, Elena Masselli, Lilian Varricchio, Carolyn Whitsett
Abstract: Blood transfusion is indispensable for modern medicine. In developed countries, the blood supply is adequate and safe but blood for alloimmunized patients is often unavailable. Concerns are ...
-
The investigation and treatment of secondary anaemia
02 December 2011
Sarah L. Davis, T.J. Littlewood
Abstract: Secondary anaemia or the anaemia of chronic disease (ACD) is the commonest form of anaemia in hospitalised patients and the second most prevalent anaemia worldwide after iron deficiency. It ...
-
MDS: Refining existing therapy through improved biologic insights
02 December 2011
Jordan Schecter, Naomi Galili, Azra Raza
Abstract: Advances in therapy can essentially be measured using two parameters; introduction of a new agent which benefits an increased number of patients over prevailing treatments or more selective ...
-
Apoptosis in the anucleate platelet
07 November 2011
Valery Leytin
Abstract: For many years, programmed cell death, known as apoptosis, was attributed exclusively to nucleated cells. Currently, however, apoptosis is also well-documented in anucleate platelets. This r...
View More Articles in Press...
